Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
9.07
0.23 (2.60%)
At close: Aug 18, 2025, 3:59 PM
8.90
-1.92%
After-hours: Aug 18, 2025, 07:46 PM EDT
Emergent BioSolutions Revenue
Emergent BioSolutions reported an annual revenue of $1.01B, reflecting a -3.4% growth. For the quarter ending June 30, 2025, Emergent BioSolutions generated $140.9M in revenue.
Revenue (ttm)
1.01B
Revenue Growth
-3.4%
Price / Sales Ratio
0.5
Revenue / Employee
1.13M
Employees
900
Market Cap
484.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 1.01B | -3.40% |
Dec 31, 2023 | 1.05B | -6.39% |
Dec 31, 2022 | 1.12B | -37.47% |
Dec 31, 2021 | 1.79B | +15.26% |
Dec 31, 2020 | 1.56B | +40.63% |
Dec 31, 2019 | 1.11B | +41.36% |
Dec 31, 2018 | 782.4M | +39.50% |
Dec 31, 2017 | 560.87M | +14.75% |
Dec 31, 2016 | 488.78M | -6.50% |
Dec 31, 2015 | 522.79M | +16.14% |
Dec 31, 2014 | 450.14M | +43.93% |
Dec 31, 2013 | 312.75M | +10.95% |
Dec 31, 2012 | 281.89M | +3.11% |
Dec 31, 2011 | 273.38M | -4.47% |
Dec 31, 2010 | 286.17M | +21.89% |
Dec 31, 2009 | 234.79M | +31.49% |
Dec 31, 2008 | 178.55M | -2.38% |
Dec 31, 2007 | 182.91M | +19.76% |
Dec 31, 2006 | 152.73M | +16.87% |
Dec 31, 2005 | 130.69M | +56.52% |
Dec 31, 2004 | 83.49M | +49.71% |
Dec 31, 2003 | 55.77M | -28.99% |
Dec 31, 2002 | 78.54M | +73.35% |
Dec 31, 2001 | 45.31M | n/a |